Journal of Pharmaceutics & Drug Delivery Research ISSN: 2325-9604

Reach Us +1 209 730 0872
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article, J Pharm Drug Deliv Res Vol: 4 Issue: 2

Enhanced Cytotoxic Effect of Chemically Conjugated Polymeric Sirolimus against HT-29 Colon Cancer and A-549 Lung Cancer Cell Lines

Bontha Venkata Subrahmanya Lokesh* and Palanirajan Vijayaraj Kumar
Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, UCSI University, Malaysia
Corresponding author : Bontha Venkata Subrahmanya Lokesh
Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Jalan Menara Gading, UCSI University(South Campus), Taman Connaught, Cheras 56000, Kuala Lumpur, Malaysia
Tel: 03-91018880
E-mail: [email protected]; [email protected]
Received: March 16, 2015 Accepted: September 30, 2015 Published: September 07, 2015
Citation: Lokesh BVS, Kumar PV (2015) Enhanced Cytotoxic Effect of Chemically Conjugated Polymeric Sirolimus against HT-29 Colon Cancer and A-549 Lung Cancer Cell Lines. J Pharm Drug Deliv Res 4:2. doi:10.4172/2325-9604.1000132

Abstract

Enhanced Cytotoxic Effect of Chemically Conjugated Polymeric Sirolimus against HT-29 Colon Cancer and A-549 Lung Cancer Cell Lines

Background/Aim

Sirolimus (SR) is highly protein binding drug (92%) and lipophilic (log P=4.917) in nature. It has half life of 57- 63hrs and oral bioavailability is 20% even less when after eating food rich in fat. In our objective of the study, SR is chemically conjugated with biodegradable polymers like methoxy-polyethylene glycolic acid (mPEG COOH) and Poly(Lactic-co glycolic acid) (PLGA). It was ensured that there is a structurally correlation among the chemical structures of SR, mPEG COOH-SR conjugate, PLGA-SR conjugate, PLGA and m-PEG COOH polymers.

Methods/Materials

The cytotoxicity assay of both conjugates was carried out on specific A-549 lung cancer and HT-29 colon cancer cell lines using vincristine sulfate, tamoxifen and cisplatin as controls separately.

Results

All results were shown the positive effects of PLGA-SR and cisplatin with IC50 values of 2.88 μg/ml and 9 μg/ml indicatively more active than cisplatin in vitro. Whereas mPEG-SR conjugate was similar activity of cisplatin with IC50 value of 8.88 μg/ml on A-549 lung cancer cell line. Both conjugates were not shown any cytotoxicity activity on 3T3 fibroblast normal cell lines. On the other hand, PLGA-SR conjugate was nine times more active than vincristine sulfate with IC50 value of 7μg/ml, whereas MPEGSR conjugate is more active than other controls and SR alone on HT-29 colon cancer cell line. These results are indicated that both conjugates with potent cytotoxicity activity against specific lung cancer and colon cancer types than SR alone.

Conclusion

Polymeric conjugation is a useful approach in a novel drug delivery system. These conjugates are basic precursors to formulate into novel drug delivery systems especially in as nanocarriers for better release with surface modification to enter the tumor cells with significant increase in the bioavailability.

Keywords: Sirolimus; Polymeric sirolimus; A-549-lung cancer cell line; HT-29 colon cancer cell line; Nanocarriers

Track Your Manuscript

Share This Page